/Danaher%20Corp_%20logo%20on%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Washington, DC-based Danaher Corporation (DHR) is a leading global life sciences and diagnostics innovator, helping solve many of the world’s most important health challenges. It focuses on areas such as Life Sciences, Diagnostics, Biotechnology, and more. Valued at $145 billion by market cap, Danaher employs thousands of people and operates in 50+ countries and 700 different locations across the globe.
The healthcare giant is gearing up to announce its third-quarter results before the market opens on Tuesday, Oct. 21. Ahead of the event, analysts expect Danaher to report an adjusted profit of $1.72 per share, marginally up from $1.71 per share reported in the year-ago quarter. The company has a mixed earnings surprise history. While it missed the Street’s bottom-line estimates once over the past four quarters, it surpassed the projections on three other occasions.
